The Market Doesn't Like What It Sees From Intco Medical Technology Co., Ltd.'s (SZSE:300677) Earnings Yet
Intco Medical Technology (300677.SZ) mainly uses clean coal, which further reduces the company's energy consumption costs compared to competitors who use henry hub natural gas, steam, and other energy sources.
On July 24th, InTco Medical Technology (300677.SZ) expressed on the investor interaction platform that, as a global leader in the disposable glove industry, the company has continuously strengthened its advantages upstream and downstream in the industry chain, and continuously carried out cost-saving and efficiency-increasing work in all aspects. After the first quarter report, cost advantages are highlighted. First, based on years of equipment integration experience and continuous improvement and innovation, the company has built the third generation production line through independent research and development. On the basis of ensuring product quality, it has industry-leading production line speed, lower energy consumption, and lower weight control level. Second, in terms of energy, the company mainly uses clean energy.
Intco Medical Technology (300677.SZ): The company's overseas orders are mainly in the form of FOB orders, and the marine transportation costs are borne by the customer.
Intco Medical Technology (300677.SZ) stated on the investor interaction platform on July 24th that its overseas orders are mainly in the form of FOB orders, and marine transportation costs are borne by the customers. At the same time, the company has signed a long-term stable strategic cooperation agreement with top marine transportation groups, and the company's support department actively utilizes company resources to help customers find suitable shipping solutions, fully ensuring high-level service quality for customers.
Since the beginning of this year, Intco Medical Technology (300677.SZ) has maintained full production and sales with a lead time of 2-3 months for orders.
Intco Medical Technology (300677.SZ) said on the investor interaction platform on July 24 that from the second half of 2023, the inventory backlog in the downstream of the industry has entered the final digestion stage. The effect of clearing high-cost and outdated production capacity has become apparent, and the concentration of the industry's supply side has increased. The overall production capacity utilization rate of the industry's leading enterprises has generally increased, and the supply-demand relationship has gradually returned to a balanced trend. Since the beginning of this year, the company has maintained full production and sales, with a lead time of 2-3 months and a slight increase in the price of disposable gloves compared to the previous period.
Intco Medical Technology's H1 Profit to Soar Up to 112%
Intco Medical Technology: 2024 Interim Performance Forecast
Selected announcements from gelonghui: Intco Medical Technology expects a year-on-year increase in net income of 87.61% to 111.49% in the first half of the year; Dazhong Transportation (Group) Co., Ltd.: The intelligent networked car model is currently in
[Investment Project] Shenzhen Nanshan Power (000037.SZ): Planning to invest in Zhongshan Cuiheng New District 300MW/600MWH independent energy storage power station (Phase I) project. Offshore Oil Engineering (600583.SH): Signed a $0.523 billion overseas project contract. [Contract Awarded] China Railway Signal & Communication Corporation (688009.SH): Won a total of five important projects from May to June, with a total amount of about CNY 1.473 billion. Hangzhou Anysoft Information Technology (300571.SZ): Expected to be awarded a CNY 30.8777 million project from China Telecom. [Equity Acquisition] Gold Cup Electric Apparatus (002533.SZ): Planning to purchase with CNY 55 million.
With full production capacity and increased selling price, Intco Medical Technology (300677.SZ) is expected to have a net profit of 550-620 million yuan in the first half of the year, with a surge of 87.61% - 111.49%.
Intco Medical Technology (300677.SZ) has released a performance forecast for the first half of 2024, with a net profit attributable to shareholders of the listed company...
Intco Medical Technology (300677.SZ): completed share buyback, cumulatively spent approximately 0.1 billion yuan to repurchase 4.5043 million shares.
On July 15th, Gelonhui reported that as of July 13th, 2024, Intco Medical Technology (300677.SZ) had repurchased a total of 4.5043 million shares of the company through the stock repurchase special securities account using centralized bidding trading method according to the stock repurchase plan, accounting for 0.6952% of the company's total current share capital, with a highest fill price of 23.75 yuan/share and a lowest fill price of 21.35 yuan/share. The total transaction amount was approximately RMB 0.1 billion yuan (excluding transaction costs). As of July 13th, 2024, the stock repurchase plan has been fully implemented upon the expiration of the repurchase period.
Intco Medical Technology (SZSE:300677) Jumps 9.7% This Week, Though Earnings Growth Is Still Tracking Behind Five-year Shareholder Returns
Intco Medical Technology (300677.SZ): Has repurchased 0.695% of the shares accumulated.
Intco Medical Technology (300677.SZ) announced that as of June 30, 2024, the company has cumulatively repurchased 4,504,300 shares through a share repurchase dedicated securities account in a centralized bidding trading method, accounting for 0.6952% of the company's total equity (calculated based on a total of 647,896,329 shares on June 30, 2024), with a highest fill price of 23.75 yuan/share, a lowest fill price of 21.35 yuan/share, and a total trade amount of RMB 100,015,581.00 (excluding transaction fees).
Intco Medical Technology Co., Ltd.'s (SZSE:300677) 4.0% Gain Last Week Benefited Both Retail Investors Who Own 47% as Well as Insiders
British Healthcare (300677.SZ) spent a total of 100 million yuan to buy back 4,504,300 shares
British Healthcare (300677.SZ) announced that the company has cumulatively repurchased the company's shares as of May 31, 2024...
The Returns On Capital At Intco Medical Technology (SZSE:300677) Don't Inspire Confidence
British Healthcare (300677.SZ) 2023 equity distribution: $0.80 for every 10 shares, share registration on May 30
British Healthcare (300677.SZ) issued an announcement. The company's 2023 equity distribution plan is: Based on the company's existing...
British Healthcare (300677.SZ): Intended to participate in Anhui Hongtai Hekang Phase I Venture Capital Fund Partnership
Gelonghui, May 17丨British Healthcare (300677.SZ) announced that in order to further optimize the investment structure and enhance investment value, Inke Medical Technology Co., Ltd. (“English Healthcare” or the “Company”) plans to sign the “Anhui Hongtai Hecang Phase I Venture Capital Fund Partnership (Limited Partnership)” with Hefei Hongtai Shengda Venture Capital Co., Ltd. (hereinafter referred to as “Hefei Hongtai”) to participate in the investment of Anhui Hongtai Hecang Phase I Venture Capital Fund Partnership (Limited Partnership) with its own funds Exactly, the following Abbreviated as a “partnership” or “foundation”
Intco Medical Technology Co., Ltd.'s (SZSE:300677) Stock Is Rallying But Financials Look Ambiguous: Will The Momentum Continue?
British Healthcare (300677.SZ): Disposable gloves remained at full production and sales in the second quarter
Gelonghui May 10 丨 British Healthcare (300677.SZ) held a performance briefing on May 9, 2024 to discuss “What was the company's order situation in the second quarter, can production be fully completed, and what is the price of gloves?” The company replied that the company maintained full production and sales of disposable gloves in the second quarter, and that the price of gloves increased to a certain extent compared to the first quarter.
Improved Earnings Required Before Intco Medical Technology Co., Ltd. (SZSE:300677) Stock's 26% Jump Looks Justified
What Does Intco Medical Technology Co., Ltd.'s (SZSE:300677) Share Price Indicate?
No Data